2 news items
Expert Ratings For Apellis Pharmaceuticals
APLS
15 Apr 24
(NASDAQ:APLS) over the past quarter, offering a diverse set of opinions from bullish to bearish.
In the table below, you'll find a summary
Decoding 15 Analyst Evaluations For Apellis Pharmaceuticals
APLS
27 Mar 24
in the last three months, revealing a diverse range of perspectives from bullish to bearish.
The following table encapsulates their recent ratings
- Prev
- 1
- Next